Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Cancers|October 17, 2020
From Tumor Mutational Burden to Blood T Cell Receptor: Looking for the Best Predictive Biomarker in Lung Cancer Treated with ImmunotherapyAndrea Sesma, Julián Pardo, Mara Cruellas, et al.Cancer Treatment Reviews|February 5, 2023
Germline TP53 pathogenic variants and breast cancer: A narrative reviewEva Blondeaux, Luca Arecco, Kevin Punie, et al.Frontiers in Genetics|March 13, 2024
Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysisNatalia Alonso, Sebastián Menao, Rodrigo Lastra, et al.Journal of Medical Genetics|November 29, 2022
Clinical and psychological implications of secondary and incidental findings in cancer susceptibility genes after exome sequencing in patients with rare disordersEstela Carrasco, Adrià López-Fernández, Marta Codina-Sola, et al.Cancer Control : Journal of the Moffitt Cancer Center|July 30, 2025
Revisiting Alma Ata: A Blueprint for Cancer CareJavier-David Benitez-Fuentes, Rodrigo Lastra Del Prado, Miguel Borregon-Rivilla, et al.Heliyon|July 25, 2024
Impact of antibiotics, corticosteroids, and microbiota on immunotherapy efficacy in patients with non-small cell lung cancerMaría Zapata-García, Alba Moratiel-Pellitero, Dolores Isla, et al.International Journal of Cancer|July 12, 2025
Performance of upper gastrointestinal endoscopy in CDH1 germline pathogenic variant carriers: A multicenter studyJoaquín Castillo-Iturra, Joan Llach, Irina Luzko, et al.Ecancermedicalscience|March 4, 2026
Oncology with common sense: beyond biologistic and pharmacological modelsRodrigo Lastra, Patricia Iranzo, Javier-David Benítez-Fuentes, et al.Journal of the National Cancer Institute|April 2, 2025
A randomized study of 2 risk assessment models for individualized breast cancer risk estimationAdrià López-Fernández, Laura Duran-Lozano, Guillermo Villacampa, et al.BJU International|June 5, 2024
The psychosocial impact of prostate cancer screening for BRCA1 and BRCA2 carriersElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.Pageof 3